Year archive

Cutia Therapeutics — 2023 filings

All 41 regulatory filings released by Cutia Therapeutics (2487) in 2023, sourced directly from the official regulator.

41 Filings

2023 Period

2023 filings (41)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT - RESULTS OF PHASE III CLINICAL TRIALS OF CU-40102 (TOPICAL FINASTERIDE SPRAY) AND CU-10201 (TOPICAL 4% MINOCYCLINE FOAM) IN THE PRC PUBLISHED AT THE 18TH CDA ANNUAL MEETING Regulatory Filings	2023-12-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023 Regulatory Filings	2023-12-06	English
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL OF CU-20401 (RECOMBINANT MUTANT COLLAGENASE) FOR ABDOMINAL ADIPOSE ACCUMULATION COMPLETED DATABASE LOCK Regulatory Filings	2023-11-27	English
OPERATIONAL UPDATE FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2023 AND THIRD QUARTER OF 2023 Regulatory Filings	2023-11-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023 Regulatory Filings	2023-11-03	English
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL OF CU-40101 (TOPICAL SMALL MOLECULE THYROID HORMONE RECEPTOR AGONIST LINIMENT) IN CHINA REACHED PRIMARY ENDPOINT Regulatory Filings	2023-11-02	English
VOLUNTARY ANNOUNCEMENT - ALL ENROLLED PATIENTS COMPLETED PHASE I CLINICAL TRIAL OF CU-20401 (RECOMBINANT MUTANT COLLAGENASE) FOR ABDOMINAL ADIPOSE ACCUMULATION Regulatory Filings	2023-10-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023 Regulatory Filings	2023-10-06	English
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION FOR CU-10201 (TOPICAL 4% MINOCYCLINE FOAM) ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2023-09-27	English
Interim Report 2023 Interim / Quarterly Report	2023-09-21	English
VOLUNTARY ANNOUNCEMENT - REGISTRATIONAL PHASE III CLINICAL TRIAL OF CU-40102 (TOPICAL FINASTERIDE SPRAY) REACHED PRIMARY ENDPOINT Regulatory Filings	2023-09-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023 Regulatory Filings	2023-09-06	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023 Share Issue/Capital Change	2023-09-06	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023 Share Issue/Capital Change	2023-09-06	English
VOLUNTARY ANNOUNCEMENT - INCLUSION OF THE COMPANY IN THE LIST FOR SOUTHBOUND TRADING LINK UNDER THE SHANGHAI-HONG KONG STOCK CONNECT AND THE SHENZHEN-HONG KONG STOCK CONNECT Regulatory Filings	2023-09-05	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023 Interim / Quarterly Report	2023-08-29	English
DISCLOSEABLE TRANSACTIONS - SUBSCRIPTIONS OF WEALTH MANAGEMENT PRODUCTS Regulatory Filings	2023-08-28	English
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL OF CU-40101 (TOPICAL SMALL MOLECULE THYROID HORMONE RECEPTOR AGONIST LINIMENT) COMPLETED DATABASE LOCK Regulatory Filings	2023-08-28	English
VOLUNTARY ANNOUNCEMENT - ALL ENROLLED PATIENTS COMPLETED PHASE III CLINICAL TRIAL OF CU-30101 (LOCALIZED TOPICAL LIDOCAINE AND TETRACAINE CREAM) Regulatory Filings	2023-08-23	English
VOLUNTARY ANNOUNCEMENT - INCLUSION OF THE COMPANY AS A CONSTITUENT STOCK OF THE HANG SENG FAMILY OF INDEXES Regulatory Filings	2023-08-18	English
DATE OF BOARD MEETING Regulatory Filings	2023-08-17	English
VOLUNTARY ANNOUNCEMENT - CU-10201 (TOPICAL 4% MINOCYCLINE FOAM) HAS BEEN GRANTED PRIORITY REVIEW DESIGNATION BY THE CENTER FOR DRUG EVALUATION OF THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2023-08-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023 Share Issue/Capital Change	2023-08-04	English
OPERATIONAL UPDATE FOR THE SECOND QUARTER AND FIRST HALF OF 2023 Regulatory Filings	2023-08-02	English
VOLUNTARY ANNOUNCEMENT - ALL ENROLLED PATIENTS COMPLETED PHASE I CLINICAL TRIAL OF CU-40101 (TOPICAL SMALL MOLECULE THYROID HORMONE RECEPTOR AGONIST LINIMENT) Regulatory Filings	2023-07-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023 Share Issue/Capital Change	2023-07-06	English
STABILIZING ACTIONS, END OF STABILIZATION PERIOD AND LAPSE OF THE OVER-ALLOTMENT OPTION Capital/Financing Update	2023-07-05	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2023-06-09	English
Terms of Reference for the Nomination Committee Governance Information	2023-06-09	English
Terms of Reference for the Remuneration Committee Remuneration Information	2023-06-09	English
Terms of Reference for the Audit Committee Governance Information	2023-06-09	English
FIFTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2023-06-09	English
ANNOUNCEMENT OF OFFER PRICE AND ALLOTMENT RESULTS Regulatory Filings	2023-06-09	English
GLOBAL OFFERING Capital/Financing Update	2023-05-31	English
Documents on Display Regulatory Filings	2023-05-31	English
GREEN APPLICATION FORM Capital/Financing Update	2023-05-31	English
GLOBAL OFFERING Capital/Financing Update	2023-05-31	English
GLOBAL OFFERING Capital/Financing Update	2023-05-31	English
PHIP (1st submission) Audit Report / Information FY 2022	2023-05-22	English
PHIP (1st submission) Regulatory Filings	2023-05-22	English
OC Announcement - Termination Capital/Financing Update	2023-05-17	English